Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab + PRP in PDR
NCT01746563Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- May 2011
- Primary completion
- Aug 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Universidade de São Paulo. Started May 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01746563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746563.